IL99145A - 3-(3-substituted 1,2,5-thia (or oxa) diazol-4-yl)-1,2,5,6- tetrahydropyridine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

3-(3-substituted 1,2,5-thia (or oxa) diazol-4-yl)-1,2,5,6- tetrahydropyridine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL99145A
IL99145A IL9914591A IL9914591A IL99145A IL 99145 A IL99145 A IL 99145A IL 9914591 A IL9914591 A IL 9914591A IL 9914591 A IL9914591 A IL 9914591A IL 99145 A IL99145 A IL 99145A
Authority
IL
Israel
Prior art keywords
thiadiazol
tetrahydro
methylpyridine
pyridine
methyl
Prior art date
Application number
IL9914591A
Other languages
English (en)
Other versions
IL99145A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL99145A0 publication Critical patent/IL99145A0/xx
Publication of IL99145A publication Critical patent/IL99145A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL9914591A 1990-08-21 1991-08-09 3-(3-substituted 1,2,5-thia (or oxa) diazol-4-yl)-1,2,5,6- tetrahydropyridine derivatives their preparation and pharmaceutical compositions containing them IL99145A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK198390A DK198390D0 (da) 1990-08-21 1990-08-21 Heterocykliske forbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
IL99145A0 IL99145A0 (en) 1992-07-15
IL99145A true IL99145A (en) 1996-10-31

Family

ID=8109264

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9914591A IL99145A (en) 1990-08-21 1991-08-09 3-(3-substituted 1,2,5-thia (or oxa) diazol-4-yl)-1,2,5,6- tetrahydropyridine derivatives their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (2) US5328924A (da)
EP (1) EP0544756B1 (da)
JP (1) JP3100158B2 (da)
AT (1) ATE159940T1 (da)
AU (1) AU660937B2 (da)
CA (1) CA2089767C (da)
DE (1) DE69128145T2 (da)
DK (1) DK198390D0 (da)
ES (1) ES2110997T3 (da)
FI (1) FI111640B (da)
IE (1) IE912958A1 (da)
IL (1) IL99145A (da)
NO (1) NO302414B1 (da)
NZ (1) NZ239451A (da)
PT (1) PT98734B (da)
WO (1) WO1992003430A1 (da)
ZA (1) ZA916579B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
HU221729B1 (hu) * 1993-08-19 2002-12-28 Novo Nordisk A/S Tiadiazolil-piridin-származékok alkalmazása antipszichotikus gyógyszerek előállítására
US5545638A (en) * 1993-12-21 1996-08-13 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
IL112024A (en) * 1993-12-21 1999-07-14 Novo Nordisk As Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders
US5998404A (en) 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5821371A (en) * 1994-10-24 1998-10-13 Eli Lilly And Comany Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
JP2000509044A (ja) * 1996-04-23 2000-07-18 イーライ・リリー・アンド・カンパニー ヘテロサイクリック化合物群
WO1997040043A1 (en) * 1996-04-23 1997-10-30 Eli Lilly And Company Heterocyclic compounds
US6117883A (en) * 1996-04-23 2000-09-12 Eli Lilly And Company Heterocyclic compounds
CA2252563A1 (en) * 1996-04-24 1997-10-30 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
AU4338399A (en) 1998-06-10 1999-12-30 Motion Design, Inc. Box with an internal resilient element
US6376675B2 (en) * 1999-01-22 2002-04-23 The University Of Toledo Muscarinic receptor agonists
US6158589A (en) 1999-09-23 2000-12-12 Motion Design, Inc. Boxes with internal resilient elements
US6311843B1 (en) 1999-10-01 2001-11-06 Motion Design, Inc. Packaging boxes and components with internal resilient elements
US6302274B1 (en) 1999-12-01 2001-10-16 Sealed Air Corporation (Us) Suspension and retention packaging structures and methods for forming same
US6490844B1 (en) 2001-06-21 2002-12-10 Emerging Technologies Trust Film wrap packaging apparatus and method
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
JP2013516497A (ja) 2010-01-11 2013-05-13 ミスリィディオン，インク． 認知増強のための化合物と組成物、製造方法、および治療方法
WO2012033956A1 (en) 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility
US11534434B2 (en) 2019-11-15 2022-12-27 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0322182A3 (en) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DE3905775A1 (de) 1989-02-24 1990-08-30 Kat Tec Ges Fuer Katalysatorte Verfahren und vorrichtung zur reduzierung von schadstoffen eines verbrennungsverfahrens mit oxidations-wabenkatalysatoren und katalysatoren mit entschwefelungseigenschaften und abgasrueckfuehrung
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
EP0544756B1 (en) 1997-11-05
ES2110997T3 (es) 1998-03-01
AU8416991A (en) 1992-03-17
DE69128145T2 (de) 1998-05-20
PT98734B (pt) 1999-01-29
NO930599D0 (no) 1993-02-19
CA2089767A1 (en) 1992-02-22
CA2089767C (en) 2005-05-03
DK198390D0 (da) 1990-08-21
AU660937B2 (en) 1995-07-13
DE69128145D1 (de) 1997-12-11
JP3100158B2 (ja) 2000-10-16
ZA916579B (en) 1992-05-27
ATE159940T1 (de) 1997-11-15
US5534528A (en) 1996-07-09
FI930745A0 (fi) 1993-02-19
NO302414B1 (no) 1998-03-02
NZ239451A (en) 1994-09-27
FI111640B (fi) 2003-08-29
US5328924A (en) 1994-07-12
WO1992003430A1 (en) 1992-03-05
JPH06501682A (ja) 1994-02-24
FI930745L (fi) 1993-03-30
PT98734A (pt) 1992-08-31
EP0544756A1 (en) 1993-06-09
IL99145A0 (en) 1992-07-15
IE912958A1 (en) 1992-02-26
NO930599L (no) 1993-04-19

Similar Documents

Publication Publication Date Title
IL99145A (en) 3-(3-substituted 1,2,5-thia (or oxa) diazol-4-yl)-1,2,5,6- tetrahydropyridine derivatives their preparation and pharmaceutical compositions containing them
US5919805A (en) Hetrocyclic compounds and their preparation and use
US5284859A (en) Piperidine compounds and their use
EP0544714B1 (en) Heterocyclic compounds and their preparation and use
EP0349956A1 (en) Azacyclic compounds and their preparation und use
US5328925A (en) Piperidine compounds and their use
US5260311A (en) Piperidine compounds and their use
US5264444A (en) Piperidine compounds and use
USRE35822E (en) Heterocyclic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees